Clinical Trial Update: Carnitine for the Treatment of Atherosclerosis. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating carnitine for the treatment of metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Carnitine (L-carnitine)

Snippet

Sponsor: Dr. Amer Johri | Conditions: Metabolic Syndrome | Phase 2 | Status: COMPLETED